Trademark Overview
On Friday, November 15, 2024, a trademark application was filed for DEEPCAUSALAI with the United States Patent and Trademark Office. The USPTO has given the DEEPCAUSALAI trademark a serial number of 98855929. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, June 2, 2025. This trademark is owned by Prescriptive Genomics, Inc. The DEEPCAUSALAI trademark is filed in the Advertising, Business and Retail Services, Computer & Software Products & Electrical & Scientific Products, Insurance & Financial Services, and Computer & Software Services & Scientific Services categories with the following description:
Downloadable computer software for producing financial models; Downloadable computer software using artificial intelligence (AI) for drug discovery and development; Downloadable computer software using artificial intelligence (AI) for therapeutic drug selection and optimization; Downloadable computer software using artificial intelligence (AI) for predicting drug effectiveness, interactions and side effects; Downloadable computer software using artificial intelligence (AI) for therapeutic target selection and optimization; Downloadable computer software using artificial intelligence (AI) for drug design; Downloadable computer software using artificial intelligence (AI) for collecting, analyzing and organizing data in the field of deep learning; Downloadable computer software using artificial intelligence (AI) for generating personal patient treatment plans based on predictive analytics; Downloadable computer software using artificial intelligence (AI) for patient management, treatment,...
Financial analysis, namely, compiling and analyzing statistics, data and other sources of information for financial purposes; Financial data analysis; Financial risk assessment services; Financial advisory and consultancy services, namely, compiling and analyzing statistics, data and other sources of information for financial purposes; Financial advisory and consultancy services, namely, in the area of healthcare
Analyzing and compiling business data for making predictions based on data inputs; Business data analysis; Business research and data analysis services in the field of patient treatment managment; Compiling and analyzing statistics, data and other sources of information for business purposes
Computer software design; Developing computer software; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for drug discovery and development; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for therapeutic drug selection and optimization; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for predicting drug effectiveness, interactions and side effects; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for drug design; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for generating personal patient treatment plans based on predictive analytics; Software authoring; Software design and development